Intelicanna Stock Net Asset

INTL Stock   98.20  0.00  0.00%   
Intelicanna fundamentals help investors to digest information that contributes to Intelicanna's financial success or failures. It also enables traders to predict the movement of Intelicanna Stock. The fundamental analysis module provides a way to measure Intelicanna's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelicanna stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Intelicanna Company Net Asset Analysis

Intelicanna's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, Intelicanna has a Net Asset of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers-Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).

Intelicanna Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelicanna's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelicanna could also be used in its relative valuation, which is a method of valuing Intelicanna by comparing valuation metrics of similar companies.
Intelicanna is currently under evaluation in net asset category among its peers.

Intelicanna Fundamentals

About Intelicanna Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Intelicanna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelicanna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelicanna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Intelicanna Stock

Intelicanna financial ratios help investors to determine whether Intelicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intelicanna with respect to the benefits of owning Intelicanna security.